Giorgos Bamias

About Giorgos Bamias

Giorgos Bamias, With an exceptional h-index of 49 and a recent h-index of 33 (since 2020), a distinguished researcher at National and Kapodistrian University of Athens, specializes in the field of Gastroenterology, Mucosal Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease

P808 Use of intestinal ultrasound influences the proportion of suboptimally controlled patients: IBD Podcast Study results

Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel Disease

P732 Lack of concordance between patient-reported, physician-reported and objective criteria-based identification of suboptimal control in IBD patients: IBD PODCAST study results

Comparison between tofacitinib and ustekinumab as a third‐line therapy in refractory ulcerative colitis: A multicenter international study

GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis (vol 185, pg 283, 2022)

P290 Evaluation of response to chronic and acute stress in patients with Crohn’s disease

TL1A/DR3 signaling regulates the generation of pathogenic Th9 cells in experimental inflammatory bowel disease

Giorgos Bamias Information

University

Position

___

Citations(all)

7681

Citations(since 2020)

3154

Cited By

5761

hIndex(all)

49

hIndex(since 2020)

33

i10Index(all)

91

i10Index(since 2020)

82

Email

University Profile Page

National and Kapodistrian University of Athens

Google Scholar

View Google Scholar Profile

Giorgos Bamias Skills & Research Interests

Gastroenterology

Mucosal Immunology

Top articles of Giorgos Bamias

Title

Journal

Author(s)

Publication Date

ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease

Journal of Crohn's and Colitis

Hannah Gordon

Johan Burisch

Pierre Ellul

Konstantinos Karmiris

Konstantinos Katsanos

...

2024/1/1

P808 Use of intestinal ultrasound influences the proportion of suboptimally controlled patients: IBD Podcast Study results

Journal of Crohn's and Colitis

A Dignass

F D'Amico

F Gomollón

G Bamias

T Heatta-Speicher

...

2024/1/1

Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel Disease

Inflammatory Bowel Diseases

Ioannis Drygiannakis

George Kolios

Eirini Filidou

Giorgos Bamias

Vassilis Valatas

2024/4/6

P732 Lack of concordance between patient-reported, physician-reported and objective criteria-based identification of suboptimal control in IBD patients: IBD PODCAST study results

Journal of Crohn's and Colitis

F D'Amico

F Gomollón

G Bamias

F Magro

T Heatta-Speicher

...

2024/1/1

Comparison between tofacitinib and ustekinumab as a third‐line therapy in refractory ulcerative colitis: A multicenter international study

United European Gastroenterology Journal

Mariangela Allocca

Gaia Catalano

Edoardo V Savarino

María Chaparro

Asaf Levartovsky

...

2024/2/28

GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis (vol 185, pg 283, 2022)

Cell

Nitish Rana

Giuseppe Privitera

Hannah C Kondolf

Katarzyna Bulek

Susana Lechuga

...

2022/1/20

P290 Evaluation of response to chronic and acute stress in patients with Crohn’s disease

Journal of Crohn's and Colitis

E Laoudi

D Papalouka

M Gkizis

G Kokkotis

ML Chatzinicolaou

...

2024/1/1

TL1A/DR3 signaling regulates the generation of pathogenic Th9 cells in experimental inflammatory bowel disease

bioRxiv

Paola Menghini

Ludovica Butto

Adrian Gomez-Nguyen

Natalia Aladyshkina

Kristine-Ann Buela

...

2024

P377 Proportion of IBD patients with suboptimal control in daily clinical practice–real-world evidence from the IBD Podcast study

Journal of Crohn's and Colitis

A Dignass

F D'Amico

F Gomollón

G Bamias

F Magro

...

2024/1/1

P942 Real-world data on outcomes of treatment with ustekinumab in patients with Ulcerative Colitis

Journal of Crohn's and Colitis

K Chalakatevaki

G Kokkotis

ML Chatzinikolaou

E Anagnostopoulou

K Argiriou

...

2024/1/1

P727 Clinical efficacy of apheresis in Ulcerative Colitis. The experience of four tertiary centers

Journal of Crohn's and Colitis

E Papathanasiou

P Markopoulos

M Tzouvala

A Ioannou

E Tsironi

...

2024/1/1

P354 Application of the clinical decision support tool to predict treatment outcomes in Crohn’s Disease patients treated with vedolizumab subcutaneous formulation

Journal of Crohn's and Colitis

P Dulai

D Lindner

C Agboton

H Alric

G Bamias

...

2023/2/1

Association Between Fatigue And Nutritional Status In Patients With Crohn’s Disease

Clinical Nutrition ESPEN

AK Karachaliou

M Bletsa

D Karayiannis

V Ioannidou

G Bamias

...

2023/4/1

P406 Observational study of the effectiveness of vedolizumab on treatment outcomes and health-related quality of life in biologic-naïve patients with Inflammatory Bowel …

Journal of Crohn's and Colitis

ML Chatzinikolaou-

C Kifnidi

G Kokkotis

A Gatopoulou

S Michopoulos

...

2023/2/1

Prevalence and predictors of arthralgia after initiation of vedolizumab in patients with inflammatory bowel disease: a retrospective cohort study

European Journal of Gastroenterology & Hepatology

Georgios Kokkotis

Evanthia Zampeli

Maria Tzouvala

Ioannis Giotis

Philippos Orfanos

...

2023/4/1

The Underappreciated Role of Secretory IgA in IBD

Giorgos Bamias

Konstantina Kitsou

Jesús Rivera-Nieves

2023/8/1

Patients with inflammatory bowel diseases have impaired antibody production after anti-SARS-CoV-2 vaccination: results from a Panhellenic Registry

Inflammatory Bowel Diseases

Eirini Zacharopoulou

Eleni Orfanoudaki

Maria Tzouvala

George Tribonias

Georgios Kokkotis

...

2023/2/1

The natural history of COVID-19 in vaccinated inflammatory bowel disease patients

Digestive and Liver Disease

N Viazis

I Drygiannakis

K Karmiris

A Theodoropoulou

E Zampeli

...

2023/3/1

Su1738 ONSCOSTATIN-M INDUCES THE EXPRESSION OF CHEMOTACTIC FACTORS’MRNA BY INTESTINAL SUBEPITHELIAL MYOFIBROBLASTS IN A PRO-INFLAMMATORY ENVIRONMENT.

Gastroenterology

GEORGE KOKKOTIS

Gesthimani Tarapatzi

Eirini Filidou

Leonidas Kandilogiannakis

Michail Spathakis

...

2023/5/1

Poor performance of predictive equations to estimate resting energy expenditure in patients with Crohn’s disease

British Journal of Nutrition

Alexandra Karachaliou

Costas Anastasiou

Maria Bletsa

Gerassimos J Mantzaris

Emmanuel Archavlis

...

2023/1

See List of Professors in Giorgos Bamias University(National and Kapodistrian University of Athens)

Co-Authors

H-index: 80
Petros P. Sfikakis

Petros P. Sfikakis

National and Kapodistrian University of Athens

H-index: 71
Fabio Cominelli

Fabio Cominelli

Case Western Reserve University

H-index: 65
George L Daikos

George L Daikos

National and Kapodistrian University of Athens

H-index: 46
George Kolios, MD, Ph.D (Athens), Ph.D (Bath)

George Kolios, MD, Ph.D (Athens), Ph.D (Bath)

Democritus University of Thrace

H-index: 28
Vassilis Valatas

Vassilis Valatas

University of Crete

academic-engine